[Autism spectrum disorder: Etiological, diagnostic and therapeutic aspects]. 2017

César Reynoso, and María José Rangel, and Virgilio Melgar
Departamentos de Neuropediatría, Centro Neurológico, Centro Médico American Birtish Cowdray, Ciudad de México, México. cealreflo@gmail.com.

Autism spectrum disorder (ASD) was described for the first time in 1943 by Leo Kanner, and since 2004, 18 490 articles in the subject have been published, which in turn have been cited 48 416 times.1 Almost half of these publications come from the United States of America and the vast maority of the efforts to improve the quality of life of these patients have taken place in developed countries. This disorder consists of an inability to acquire social and emotional skills during early development that progressively results in variable degrees of social adaptation discapacity. The etiology is multifactorial and includes functional and structural neurological abnormalities, some of them with putative genetic and/or epigenetic origin. There is an alarming lack of knowledge in the subject among health care professionals. The purpose of this systematic review is to summarize the most relevant historical, diagnostic and therapeutic aspects of ASD.

UI MeSH Term Description Entries
D008800 Mexico A country in NORTH AMERICA, bordering the Caribbean Sea and the Gulf of Mexico, between BELIZE and the UNITED STATES, and bordering the North Pacific Ocean, between Guatemala and the UNITED STATES.
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011613 Psychotherapy A generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication. Psychotherapies
D002491 Central Nervous System Agents A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252) Central Nervous System Drugs
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067877 Autism Spectrum Disorder Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V) Autistic Spectrum Disorder,Autism Spectrum Disorders,Autistic Spectrum Disorders,Disorder, Autistic Spectrum
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D018479 Early Intervention, Educational Procedures and programs that facilitate the development or skill acquisition in infants and young children who have disabilities, who are at risk for developing disabilities, or who are gifted. It includes programs that are designed to prevent handicapping conditions in infants and young children and family-centered programs designed to affect the functioning of infants and children with special needs. (From Journal of Early Intervention, Editorial, 1989, vol. 13, no. 1, p. 3; A Discursive Dictionary of Health Care, prepared for the U.S. House of Representatives Committee on Interstate and Foreign Commerce, 1976) Early Intervention (Education),Early Intervention Education,Early Intervention, Education,Head Start Program,Education Early Intervention,Education, Early Intervention,Educational Early Intervention,Head Start Programs,Intervention Education, Early,Intervention, Early (Education),Intervention, Education Early,Intervention, Educational Early,Program, Head Start

Related Publications

César Reynoso, and María José Rangel, and Virgilio Melgar
May 2008, Autism : the international journal of research and practice,
César Reynoso, and María José Rangel, and Virgilio Melgar
June 1990, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
César Reynoso, and María José Rangel, and Virgilio Melgar
September 2014, Biochemical and biophysical research communications,
César Reynoso, and María José Rangel, and Virgilio Melgar
January 2015, Boletin medico del Hospital Infantil de Mexico,
César Reynoso, and María José Rangel, and Virgilio Melgar
April 2018, Pediatrics,
César Reynoso, and María José Rangel, and Virgilio Melgar
January 2022, Neuroscience bulletin,
César Reynoso, and María José Rangel, and Virgilio Melgar
September 2001, Fortschritte der Neurologie-Psychiatrie,
César Reynoso, and María José Rangel, and Virgilio Melgar
November 2015, Paediatric anaesthesia,
César Reynoso, and María José Rangel, and Virgilio Melgar
December 2018, Journal of molecular neuroscience : MN,
César Reynoso, and María José Rangel, and Virgilio Melgar
November 2019, Paediatrics & child health,
Copied contents to your clipboard!